NK Cells from RAG- or DCLRE1C-Deficient Patients Inhibit HCMV

The recombination-activating genes (RAGs) and the DNA cross-link repair 1C gene (DCLRE1C) encode the enzymes RAG1, RAG2 and Artemis. They are critical components of the V(D)J recombination machinery. V(D)J recombination is well known as a prerequisite for the development and antigen diversity of T a...

Full description

Bibliographic Details
Main Authors: Zeguang Wu, Narmadha Subramanian, Eva-Maria Jacobsen, Kerstin Laib Sampaio, Johannes van der Merwe, Manfred Hönig, Thomas Mertens
Format: Article
Language:English
Published: MDPI AG 2019-11-01
Series:Microorganisms
Subjects:
Online Access:https://www.mdpi.com/2076-2607/7/11/546
_version_ 1818920262949666816
author Zeguang Wu
Narmadha Subramanian
Eva-Maria Jacobsen
Kerstin Laib Sampaio
Johannes van der Merwe
Manfred Hönig
Thomas Mertens
author_facet Zeguang Wu
Narmadha Subramanian
Eva-Maria Jacobsen
Kerstin Laib Sampaio
Johannes van der Merwe
Manfred Hönig
Thomas Mertens
author_sort Zeguang Wu
collection DOAJ
description The recombination-activating genes (RAGs) and the DNA cross-link repair 1C gene (DCLRE1C) encode the enzymes RAG1, RAG2 and Artemis. They are critical components of the V(D)J recombination machinery. V(D)J recombination is well known as a prerequisite for the development and antigen diversity of T and B cells. New findings suggested that RAG deficiency impacts the cellular fitness and function of murine NK cells. It is not known whether NK cells from severe combined immunodeficiency (SCID) patients with defective RAGs or DCLRE1C (RAGs<sup>&#8722;</sup>/DCLRE1C<sup>&#8722;</sup>-NK) are active against virus infections. Here, we evaluated the anti-HCMV activity of RAGs<sup>&#8722;</sup>/DCLRE1C<sup>&#8722;</sup>-NK cells. NK cells from six SCID patients were functional in inhibiting HCMV transmission between cells in vitro. We also investigated the expansion of HCMV-induced NK cell subset in the RAG- or DCLRE1C-deficient patients. A dynamic expansion of NKG2C<sup>+</sup> NK cells in one RAG-2-deficient patient was observed post HCMV acute infection. Our study firstly reveals the antiviral activity of human RAGs<sup>&#8722;</sup>/ DCLRE1C<sup>&#8722;</sup>-NK cells.
first_indexed 2024-12-20T01:18:58Z
format Article
id doaj.art-8d897f806eb642d287d4e783a28612e1
institution Directory Open Access Journal
issn 2076-2607
language English
last_indexed 2024-12-20T01:18:58Z
publishDate 2019-11-01
publisher MDPI AG
record_format Article
series Microorganisms
spelling doaj.art-8d897f806eb642d287d4e783a28612e12022-12-21T19:58:30ZengMDPI AGMicroorganisms2076-26072019-11-0171154610.3390/microorganisms7110546microorganisms7110546NK Cells from RAG- or DCLRE1C-Deficient Patients Inhibit HCMVZeguang Wu0Narmadha Subramanian1Eva-Maria Jacobsen2Kerstin Laib Sampaio3Johannes van der Merwe4Manfred Hönig5Thomas Mertens6Institute of Virology, Ulm University Medical Center, D-89081 Ulm, GermanyInstitute of Virology, Ulm University Medical Center, D-89081 Ulm, GermanyDepartment of Pediatrics and Adolescent Medicine, Ulm University Medical Center, D-89081 Ulm, GermanyInstitute of Virology, Ulm University Medical Center, D-89081 Ulm, GermanyInstitute of Molecular Virology, Ulm University Medical Center, D-89081 Ulm, GermanyDepartment of Pediatrics and Adolescent Medicine, Ulm University Medical Center, D-89081 Ulm, GermanyInstitute of Virology, Ulm University Medical Center, D-89081 Ulm, GermanyThe recombination-activating genes (RAGs) and the DNA cross-link repair 1C gene (DCLRE1C) encode the enzymes RAG1, RAG2 and Artemis. They are critical components of the V(D)J recombination machinery. V(D)J recombination is well known as a prerequisite for the development and antigen diversity of T and B cells. New findings suggested that RAG deficiency impacts the cellular fitness and function of murine NK cells. It is not known whether NK cells from severe combined immunodeficiency (SCID) patients with defective RAGs or DCLRE1C (RAGs<sup>&#8722;</sup>/DCLRE1C<sup>&#8722;</sup>-NK) are active against virus infections. Here, we evaluated the anti-HCMV activity of RAGs<sup>&#8722;</sup>/DCLRE1C<sup>&#8722;</sup>-NK cells. NK cells from six SCID patients were functional in inhibiting HCMV transmission between cells in vitro. We also investigated the expansion of HCMV-induced NK cell subset in the RAG- or DCLRE1C-deficient patients. A dynamic expansion of NKG2C<sup>+</sup> NK cells in one RAG-2-deficient patient was observed post HCMV acute infection. Our study firstly reveals the antiviral activity of human RAGs<sup>&#8722;</sup>/ DCLRE1C<sup>&#8722;</sup>-NK cells.https://www.mdpi.com/2076-2607/7/11/546human cytomegalovirusnatural killer cellsevere combined immunodeficiency
spellingShingle Zeguang Wu
Narmadha Subramanian
Eva-Maria Jacobsen
Kerstin Laib Sampaio
Johannes van der Merwe
Manfred Hönig
Thomas Mertens
NK Cells from RAG- or DCLRE1C-Deficient Patients Inhibit HCMV
Microorganisms
human cytomegalovirus
natural killer cell
severe combined immunodeficiency
title NK Cells from RAG- or DCLRE1C-Deficient Patients Inhibit HCMV
title_full NK Cells from RAG- or DCLRE1C-Deficient Patients Inhibit HCMV
title_fullStr NK Cells from RAG- or DCLRE1C-Deficient Patients Inhibit HCMV
title_full_unstemmed NK Cells from RAG- or DCLRE1C-Deficient Patients Inhibit HCMV
title_short NK Cells from RAG- or DCLRE1C-Deficient Patients Inhibit HCMV
title_sort nk cells from rag or dclre1c deficient patients inhibit hcmv
topic human cytomegalovirus
natural killer cell
severe combined immunodeficiency
url https://www.mdpi.com/2076-2607/7/11/546
work_keys_str_mv AT zeguangwu nkcellsfromragordclre1cdeficientpatientsinhibithcmv
AT narmadhasubramanian nkcellsfromragordclre1cdeficientpatientsinhibithcmv
AT evamariajacobsen nkcellsfromragordclre1cdeficientpatientsinhibithcmv
AT kerstinlaibsampaio nkcellsfromragordclre1cdeficientpatientsinhibithcmv
AT johannesvandermerwe nkcellsfromragordclre1cdeficientpatientsinhibithcmv
AT manfredhonig nkcellsfromragordclre1cdeficientpatientsinhibithcmv
AT thomasmertens nkcellsfromragordclre1cdeficientpatientsinhibithcmv